In8bio Correlations

INAB Stock  USD 0.24  0.01  4.35%   
The current 90-days correlation between In8bio Inc and Lantern Pharma is 0.17 (i.e., Average diversification). The correlation of In8bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

In8bio Correlation With Market

Average diversification

The correlation between In8bio Inc and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with In8bio Stock

  0.7VRAX Virax Biolabs GroupPairCorr

Moving against In8bio Stock

  0.53DVAX Dynavax TechnologiesPairCorr
  0.49CDTTW Conduit PharmaceuticalsPairCorr
  0.38VRTX Vertex PharmaceuticalsPairCorr
  0.35VRNA Verona Pharma PLCPairCorr
  0.33KTTAW Pasithea TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ANNXZURA
INMBLTRN
LTRNCUE
INMBANIX
ZURARVPH
ANIXLTRN
  
High negative correlations   
ZURAINMB
ANNXINMB
ANNXANIX
ZURAANIX
ANNXLTRN
ZURALTRN

Risk-Adjusted Indicators

There is a big difference between In8bio Stock performing well and In8bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze In8bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RVPH  5.20 (0.55) 0.00 (0.24) 0.00 
 11.90 
 51.04 
CUE  4.93  0.04  0.00 (0.04) 0.00 
 8.51 
 38.78 
LTRN  4.65  0.18  0.04  0.12  4.97 
 12.03 
 44.50 
GRCL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ANIX  3.36  0.27  0.06  0.12  3.77 
 7.14 
 26.44 
INMB  4.70  0.67  0.14  0.75  4.63 
 12.57 
 28.67 
PYPD  4.28  0.32  0.05  0.20  5.70 
 10.62 
 41.24 
ZURA  4.83 (0.68) 0.00 (0.38) 0.00 
 9.79 
 29.06 
ANNX  3.61 (0.77) 0.00 (0.66) 0.00 
 5.94 
 26.02 
ICVX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

In8bio Corporate Management

Pharm MPHVP CommunicationsProfile
TaiWei HoPresident, CoFounderProfile
William HoPresident, CoFounderProfile
Trishna MDChief OfficerProfile
Kate RochlinChief OfficerProfile
Lawrence LambCoFounder VPProfile